<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="In-Data-Review" Owner="NLM">        <PMID Version="1">30222029</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>14</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1557-9891</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>12</Volume>                    <Issue>6</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Nov</Month>                    </PubDate>                </JournalIssue>                <Title>American journal of men's health</Title>                <ISOAbbreviation>Am J Mens Health</ISOAbbreviation>            </Journal>            <ArticleTitle>Men With a &quot;Woman's Disease&quot;: Stigmatization of Male Breast Cancer Patients-A Mixed Methods Analysis.</ArticleTitle>            <Pagination>                <MedlinePgn>2194-2207</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1177/1557988318799025</ELocationID>            <Abstract>                <AbstractText>Male breast cancer (MBC) is rare and known as a typical woman's disease. This study is part of the N-MALE project (Male breast cancer: patient's needs in prevention, diagnosis, treatment, rehabilitation and follow-up-care) and aims to investigate how MBC patients (MBCP) feel about suffering from a &quot;woman's disease,&quot; what character the stigmatization has, and how it can be prospectively reduced. Therefore, a mixed methods design is applied including data of N = 27 qualitative interviews with MBCP and quantitative data of N = 100 MBCP. Findings identify a diverse picture, as stigmatization varies between contexts and patients: Most stigmatization concentrates on sexual stigmatization and ignorance of MBC and mostly occurs in cancer care systems and work-related contexts. The level of stigmatization varies with age and amount of treatment methods received, as reported within the created typology of different MBCP stigma types. To prospectively reduce stigmatization in MBCP, more publicity of MBC is needed, as well as gender-neutral communication and information material.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Midding</LastName>                    <ForeName>Evamarie</ForeName>                    <Initials>E</Initials>                    <AffiliationInfo>                        <Affiliation>1 Center for Health Communication and Health Services Research (CHSR). Department of Psychosomatic Medicine and Psychotherapy, University Hospital Bonn, Bonn, Germany.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>2 Center for Integrated Oncology Cologne Bonn, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Halbach</LastName>                    <ForeName>Sarah Maria</ForeName>                    <Initials>SM</Initials>                    <AffiliationInfo>                        <Affiliation>1 Center for Health Communication and Health Services Research (CHSR). Department of Psychosomatic Medicine and Psychotherapy, University Hospital Bonn, Bonn, Germany.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>2 Center for Integrated Oncology Cologne Bonn, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kowalski</LastName>                    <ForeName>Christoph</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>3 German Cancer Society (DKG), Berlin, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Weber</LastName>                    <ForeName>Rainer</ForeName>                    <Initials>R</Initials>                    <AffiliationInfo>                        <Affiliation>4 Department of Psychosomatic Medicine and Psychotherapy, University Hospital Cologne, Cologne, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>WÃ¼rstlein</LastName>                    <ForeName>Rachel</ForeName>                    <Initials>R</Initials>                    <AffiliationInfo>                        <Affiliation>5 Breast Center, Department of Gynecology and Obstetrics and CCCLMU, University of Munich (LMU), Munich, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ernstmann</LastName>                    <ForeName>Nicole</ForeName>                    <Initials>N</Initials>                    <AffiliationInfo>                        <Affiliation>1 Center for Health Communication and Health Services Research (CHSR). Department of Psychosomatic Medicine and Psychotherapy, University Hospital Bonn, Bonn, Germany.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>2 Center for Integrated Oncology Cologne Bonn, Germany.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>09</Month>                <Day>15</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>Am J Mens Health</MedlineTA>            <NlmUniqueID>101287723</NlmUniqueID>            <ISSNLinking>1557-9883</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>World J Surg Oncol. 2008 Jun 16;6:58</RefSource>                <PMID Version="1">18558006</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Health Soc Behav. 2000 Mar;41(1):50-67</RefSource>                <PMID Version="1">10750322</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Cancer. 2003 Nov 17;89(10):1834-6</RefSource>                <PMID Version="1">14612888</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Psychol Med Settings. 2008 Jun;15(2):134-9</RefSource>                <PMID Version="1">19104977</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Psychother Psychosom Med Psychol. 2017 Jul;67(7):304-311</RefSource>                <PMID Version="1">28719922</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Womens Health. 2017 Aug 2;17(1):58</RefSource>                <PMID Version="1">28768506</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Care (Basel). 2014 Feb;9(1):29-33</RefSource>                <PMID Version="1">24803884</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2011 Nov 20;29(33):4381-6</RefSource>                <PMID Version="1">21969512</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast. 2000 Dec;9(6):343-8</RefSource>                <PMID Version="1">14965759</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res. 2011 Sep 29;13(5):219</RefSource>                <PMID Version="1">22017761</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Nurs. 2007 Nov-Dec;30(6):464-70</RefSource>                <PMID Version="1">18025919</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>N Engl J Med. 2018 Jun 14;378(24):2311-2320</RefSource>                <PMID Version="1">29897847</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Behav Med. 1996 Jun;18(2):110-25</RefSource>                <PMID Version="1">24203693</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Psychooncology. 2004 Mar;13(3):147-60</RefSource>                <PMID Version="1">15022150</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Surg Oncol. 2004 Aug;11(8):751-5</RefSource>                <PMID Version="1">15289238</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Cancer. 2006 Feb;42(3):334-41</RefSource>                <PMID Version="1">16377181</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Health (London). 2015 Jul;19(4):413-29</RefSource>                <PMID Version="1">25323051</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Future Oncol. 2008 Oct;4(5):717-33</RefSource>                <PMID Version="1">18922128</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Indian J Med Paediatr Oncol. 2017 Apr-Jun;38(2):146-152</RefSource>                <PMID Version="1">28900322</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Cancer. 2013 Apr 15;132(8):1918-26</RefSource>                <PMID Version="1">22987302</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Psychosomatics. 2002 Jul-Aug;43(4):326-30</RefSource>                <PMID Version="1">12189259</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Arch Psychiatr Nurs. 2016 Apr;30(2):204-9</RefSource>                <PMID Version="1">26992872</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Sociol Health Illn. 2017 Mar;39(3):458-473</RefSource>                <PMID Version="1">27577849</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2006 Jan 1;24(1):95-101</RefSource>                <PMID Version="1">16382118</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet. 2006 Feb 11;367(9509):528-9</RefSource>                <PMID Version="1">16473129</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Psychooncology. 2018 Jan;27(1):193-198</RefSource>                <PMID Version="1">28685499</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Cancer. 2017 Nov 09;17(1):741</RefSource>                <PMID Version="1">29121876</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Psychooncology. 2016 Oct;25(10):1206-1211</RefSource>                <PMID Version="1">27421234</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">(male) breast cancer</Keyword>            <Keyword MajorTopicYN="N">MBC</Keyword>            <Keyword MajorTopicYN="N">health services research</Keyword>            <Keyword MajorTopicYN="N">medical sociology</Keyword>            <Keyword MajorTopicYN="N">mixed methods</Keyword>            <Keyword MajorTopicYN="N">rare disease</Keyword>            <Keyword MajorTopicYN="N">stigma</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>18</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>18</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>18</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30222029</ArticleId>            <ArticleId IdType="doi">10.1177/1557988318799025</ArticleId>            <ArticleId IdType="pmc">PMC6199445</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>